[go: up one dir, main page]

ES2036566T3 - Solucion conteniendo cloruro de lisocima y gliciricinato dipotasico. - Google Patents

Solucion conteniendo cloruro de lisocima y gliciricinato dipotasico.

Info

Publication number
ES2036566T3
ES2036566T3 ES198787118175T ES87118175T ES2036566T3 ES 2036566 T3 ES2036566 T3 ES 2036566T3 ES 198787118175 T ES198787118175 T ES 198787118175T ES 87118175 T ES87118175 T ES 87118175T ES 2036566 T3 ES2036566 T3 ES 2036566T3
Authority
ES
Spain
Prior art keywords
chloride
lysocima
glycricinate
dipotasic
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787118175T
Other languages
English (en)
Inventor
Yoshio Kogure
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ES2036566T3 publication Critical patent/ES2036566T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SOLUCION ACUOSA QUE CONTIENE HIDROCLORURO DE LISOZIMA, GLICIRRICINATO DIPOTASICO, POR LO MENOS UN COMPUESTO SELECCIONADO DEL GRUPO FORMADO POR CLORURO SODICO, CLORURO POTASICO, CLORURO CALCICO, CLORURO MAGNESICO, FOSFATO SODICO, FOSFATO POTASICO, CITRATO SODICO, CITRATO POTASICO, CARBONATO SODICO Y CARBONATO POTASICO, Y AGUA, TIENE UN PH DE 5 A 9 Y ES UTIL PARA EMPLEO EN GOTAS PARA LOS OJOS.
ES198787118175T 1986-12-19 1987-12-08 Solucion conteniendo cloruro de lisocima y gliciricinato dipotasico. Expired - Lifetime ES2036566T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61303163A JPH085800B2 (ja) 1986-12-19 1986-12-19 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤

Publications (1)

Publication Number Publication Date
ES2036566T3 true ES2036566T3 (es) 1993-06-01

Family

ID=17917640

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787118175T Expired - Lifetime ES2036566T3 (es) 1986-12-19 1987-12-08 Solucion conteniendo cloruro de lisocima y gliciricinato dipotasico.

Country Status (10)

Country Link
US (1) US4961927A (es)
EP (1) EP0275457B1 (es)
JP (1) JPH085800B2 (es)
KR (1) KR910005885B1 (es)
AT (1) ATE73670T1 (es)
DE (1) DE3777611D1 (es)
ES (1) ES2036566T3 (es)
GR (1) GR3004119T3 (es)
PH (1) PH24628A (es)
PT (1) PT86400B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327756B1 (en) * 1987-11-13 1994-01-26 Smithkline Beecham Farmaceutici S.p.A. Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer
JP2700465B2 (ja) * 1988-05-09 1998-01-21 関西酵素株式会社 塩化リゾチーム配合トイレタリー製品
IT8920486A0 (it) * 1989-05-12 1989-05-12 Isf Spa Composizioni farmaceutiche.
JPH06199648A (ja) * 1993-01-08 1994-07-19 Kao Corp 可溶化型化粧料
US5482710A (en) * 1993-07-30 1996-01-09 Chesebrough-Pond'usa Co., Division Of Conopco, Inc. Cosmetic composition for treatment of pimples and redness
CA2232855C (en) 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
IT1291366B1 (it) * 1997-05-14 1999-01-07 Angelini Ricerche Spa Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale
US6432424B1 (en) 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6630175B1 (en) * 2000-06-29 2003-10-07 Johnson & Johnson Consumer Companies, Inc. Method of reducing eye irritation
US6372791B1 (en) 2000-06-29 2002-04-16 Johnson & Johnson Consumer Companies, Inc. Method of promoting skin cell metabolism
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
US7678389B1 (en) * 2004-06-16 2010-03-16 Scott Cordray Treatment of optic and otic inflammation
WO2007008618A2 (en) * 2005-07-13 2007-01-18 University Of South Carolina Sterilization using high-pressure carbon dioxide
US20070264362A1 (en) * 2006-05-11 2007-11-15 Nina Yoshpe Method and composition for treating ear inflammation caused by dry ear
US20080213188A1 (en) * 2007-03-02 2008-09-04 Saint Simeon Lda Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions
JP5274826B2 (ja) * 2007-12-12 2013-08-28 サンスター株式会社 口腔用組成物
IT1401153B1 (it) * 2010-07-28 2013-07-12 Neova Technologies B V Formulazioni di lisozima gelificato
US8758836B2 (en) 2011-09-09 2014-06-24 Nina S. YOSHPE Method and formulation for treating dry ear inflammation with cortisone
WO2017209721A1 (en) 2016-06-02 2017-12-07 Alemdar Eda A drug derived from enzymes present in the human saliva for use in preventing corneal clouding or cataract formation
CN109718246A (zh) * 2019-02-19 2019-05-07 刘宝林 一种鼻腔清洗液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB843135A (en) * 1957-07-16 1960-08-04 Biorex Laboratories Ltd Glycyrrhetinic acid salts
US3419471A (en) * 1965-04-19 1968-12-31 Eisai Co Ltd Preparation of albumin-free lysozyme
FR2037000A1 (en) * 1969-04-30 1970-12-31 Pluripharm Non allergic lysozyme chlorhydrate prepn
JPS49310A (es) * 1972-04-14 1974-01-05
JPS56110609A (en) * 1980-02-06 1981-09-01 Lion Corp Composition for oral cavity
JPS5746922A (en) * 1980-09-05 1982-03-17 Ss Pharmaceut Co Ltd Stable aqueous lysozyme solution
AU553789B2 (en) * 1982-06-30 1986-07-24 Biorex Laboratories Ltd. Glycyrrhetinic acid derivatives in cream compositions
GB2122893B (en) * 1982-06-30 1985-06-26 Biorex Laboratories Ltd Glycyrrhetinic acid compositions

Also Published As

Publication number Publication date
GR3004119T3 (es) 1993-03-31
PH24628A (en) 1990-08-17
JPH085800B2 (ja) 1996-01-24
ATE73670T1 (de) 1992-04-15
JPS63156728A (ja) 1988-06-29
EP0275457A2 (en) 1988-07-27
KR880007059A (ko) 1988-08-26
DE3777611D1 (de) 1992-04-23
US4961927A (en) 1990-10-09
EP0275457B1 (en) 1992-03-18
KR910005885B1 (ko) 1991-08-06
PT86400B (pt) 1990-11-20
EP0275457A3 (en) 1988-09-07
PT86400A (en) 1988-01-01

Similar Documents

Publication Publication Date Title
ES2036566T3 (es) Solucion conteniendo cloruro de lisocima y gliciricinato dipotasico.
BR8601404A (pt) Composicao de alvejamento aquosa,estavel,espessada,de baixo ph
TR24617A (tr) Deterjan katki maddeleri olarak kullanilan enzim ihtiva eden granuele maddeler.
SE8602404D0 (sv) Ny formulering
DE3063088D1 (en) Method of forming an aqueous dialysis solution
BR9001411A (pt) Composicao aquosa detergente liquida
DE3688740D1 (de) Verfahren zur veraetherung von galaktomannanen.
ATE38097T1 (de) Stabilisierte, ein enzymkonjugat enthaltende zusammensetzung.
IL110566A0 (en) Stable aqueous solutions of hybrid alpha-interferon
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
ATE74747T1 (de) Zahnpasta.
FR2619098B1 (fr) Procede de purification de saumures concentrees d'halogenures alcalins
EP0619313A4 (en) LITHIUM SALT OF 2-0-ALKYLASCORBIC ACID.
KR860003791A (ko) 단백질 가수 분해물의 점도 조절방법
FR2601674B1 (fr) Procede de preparation d'une solution aqueuse du sel de sodium de la methionine
ES515251A0 (es) "procedimiento de fabricacion de carbonato de sodio monohidratado".
ES551363A0 (es) Procedimiento para fabricar carbonato de sodio anhidro denso
BE892931A (fr) Purification d'une solution aqueuse de carbonate d'ammonium
MA20222A1 (fr) Procede pour la preparation d'une solution aqueuse de chlorure de sodium, et procede de fabrication de bicarbonate de sodium.
UA6327A1 (uk) Спосіб одержання похідних галоідпірідіна
ATE17116T1 (de) Selektive acylierung von hydroxy-aminoarylsulfons|ure.
ES8304104A1 (es) "procedimiento para preparar composiciones de sacarina calcica y cristalizada".
MA20111A1 (fr) Sels de bis-alkylphosphonium de N-phosphonomethylglycine.
JPS649927A (en) Bathing composition
FR2534475B1 (fr) Procede de concentration d'une solution antibiotique b-lactame aqueuse

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 275457

Country of ref document: ES